Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom, surged 28% on Thursday ...

this inclusion of a message that differentiates the brand enhances the chance of an ad achieving its objective. In the case of Hims & Hers, awareness of its weight loss product is destined to ...

The weekly treatment contains compounded or off-brand semaglutide, the active ingredient in Novo Nordisk’s (NVO) popular diabetes and weight-loss treatments Ozempic and Wegovy. Where the controversy ...

The GLP-1 wars are heating up. After telehealth brand Hims & Hers aired its first Super Bowl commercial Sunday night, competitor Novo Nordisk, which makes competing weight loss drugs Ozempic and ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little ... to dispense their own versions when brand-name drugs like Ozempic are in ...

That allows management to reinvest in either acquisitions of complementary technologies, the expansion of compounding facilities, or further brand-building strategies. Hims & Hers represents a ...

Companies like Hims & Hers are allowed to offer compounded versions of Ozempic and Wegovy because the brand-name drugs are in shortage and have been for years. For consumers, it's an appealing ...

During the Super Bowl, Hims & Hers Health aired a commercial called ... health care system “broken,” all while offering the brand’s own “affordable, doctor-trusted” compounded ...